Navigation Links
Quincy Bioscience Promotes Older Driver Safety Awareness Week
Date:12/4/2013

Madison, WI (PRWEB) December 04, 2013

December is a month of holiday festivities and spending time with loved ones. For many, however, December also means a time for snow and cautious driving. Quincy Bioscience, makers of best-selling brain health supplement Prevagen®, supports Older Driver Safety Awareness Week (December 2-6, 2013).

Created by the American Occupational Therapy Association, Inc. (AOTA) and occurring the first week of December, Older Driver Safety Awareness Week is a time to promote the importance of driver safety among all individuals, particularly for older adults. Quincy Bioscience recognizes that healthy brain function plays a key role in practicing safe driving. The company conducted a 30-day research study on the company’s flagship product Prevagen (10 mg) which showed improvement in the ability to remember driving directions.

The study showed that 84% of participants experienced improvement in remembering driving directions in 30 days of taking Prevagen. The study also showed that 66% of participants reported improvement in word recall. See the full research study on the Prevagen website.

Essential calcium-binding proteins in the brain are lost during the natural process of aging which is when normal age-related memory loss can happen. Prevagen is an apoaequorin-based product that supplements these vital proteins and has been clinically test to promote clearer thinking and sharper memory. Prevagen is available in health food stores and pharmacies nationwide including Walgreens, CVS, Rite Aid, and Vitamin Shoppe. Daily use for 30-90 days is the recommended length of time to experience results.

Quincy Bioscience wishes everyone safe traveling this holiday season and encourages a proactive approach for safe driving. Learn more at http://www.prevagen.com.

About Quincy Bioscience:
Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11388878.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Quincy Bioscience Launches Complimentary Online Memory Games
2. Quincy Bioscience Launches New Version of “The Brain Health Guide”
3. Quincy Bioscience Makes Inc. 500
4. 5000 List of America’s Fastest Growing Companies
5. NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation
6. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement
7. Centrillion Biosciences Launches Cloud and Mobile-based Sequencing Application
8. Dunn Foundation awards bioscience grants
9. RANK protein promotes the initiation, progression and metastasis of human breast cancer
10. Scientists discover mechanism that promotes lung cancer growth and survival
11. Alcoholics Anonymous participation promotes long-term recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is ... KLS is a longtime supporter of the event. , "We are pleased that ... said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... pre-eminent publication and community for those in the fight against cancer, has produced ... in their success. HRA will release top-line findings in a webinar, Defining ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Curemark, LLC ... safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling ... sites already enrolling children across the United States. , “There are currently no ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and athletics. It’s enough to overwork even the sharpest brain. , Power On, ... peak healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... Feb. 23, 2017  Genesis Healthcare Services has merged ... was made by Bill Monast , President and ... and Nathan Feltman , executives with Home Health ... LLC. This acquisition helps Hospice Cloud ... technology enabled durable medical equipment (DME) solutions for the ...
(Date:2/23/2017)... ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, ... 31 December 2016 compared with the previous corresponding period. A full ... here . Highlights Profit ... Earnings per share of 2.2 cents (Dec 2015: 1.2 cents; ... up 11%) Profit before tax of $2.12m (Dec ...
Breaking Medicine Technology: